)
)
)
Jecho Laboratories
Company Description: Jecho Laboratories is a clinical-stage company focusing in oncology across fusion proteins, ADCs, TCEs, and bsAbs.
Goal for Presentation: Highlight our late preclinical and early clinical-stage assets
Additional Comments:
Who referred you to this application?:
Goal for Presentation: Highlight our late preclinical and early clinical-stage assets
Additional Comments:
Who referred you to this application?:
What is your next catalyst (value inflection) update?
Phase 1 clinical trial data from several pipeline programs
Year Founded
2013
Lead Product in Development
JL14002 - VEGF biosimilar, NDA anticipated 2026
JLM019 - CD80/PD-L1 fusion protein
Development Phase of Lead Product
NDA Preparation/In Review
Number of Unlicensed Products Looking for Licensing
~10
CEO/Top Company Official
Xiaodong Xiao, Ph.D.
When you expect your next catalyst update?
April 2026
){kind=logo}
)
)
){kind=logo}
)
){kind=logo}
){kind=logo}
){kind=logo}
